Hydrocortisone inhibition of adenosine diphosphate (ADP)-induced platelet aggregation in horse

被引：3
作者：
Casella S. [1 ]
Giudice E. [2 ]
Alberghina D. [1 ]
Giannetto C. [1 ]
Marafioti S. [1 ]
Piccione G. [1 ,3 ]
机构：
[1] Dipartimento di Scienze Sperimentali e Biotecnologie Applicate, Facoltà di Medicina Veterinaria, Università degli Studi di Messina, Messina
[2] Dipartimento di Sanità Pubblica Veterinaria, Facoltà di Medicina Veterinaria, Università degli Studi di Messina, Messina
[3] Dipartimento di Scienze Sperimentali e Biotecnologie Applicate, Facoltà di Medicina Veterinaria, Università degli Studi di Messina. Polo Universitario dell'Annunziata
来源：
Comparative Clinical Pathology | 2011年 / 20卷 / 4期
关键词：
ADP; Horse; Hydrocortisone; Platelets;
D O I：
10.1007/s00580-010-0997-2
中图分类号：
学科分类号：
摘要：
The aim of this study was to evaluate the effect of hydrocortisone on adenosine diphosphate (ADP)-induced platelet aggregation in horse. The study was carried out on 35 healthy horses of various breeds and gender. On all horses, citrated blood samples were collected by jugular venipuncture to assess platelet aggregation. On all samples, platelet-rich and platelet-poor plasma were prepared by centrifugation and divided into two different aliquots. On the first aliquot, platelet aggregation was determined after platelet activating with 1 and 0. 5 μM ADP (group A). On the last one, the effect of 20-min preincubation with hydrocortisone in ADP-induced aggregation was determined at final ADP concentrations of 1 and 0. 5 μM (group B). By means of an aggregometer, the platelet response was quantitated as maximum degree of platelet aggregation and initial velocity of platelet aggregation. All data were analyzed using unpaired Student's t test. A P ≤ 0. 05 was considered statistically significant. The obtained results showed a statistically significant effect of hydrocortisone on both the maximum degree of platelet aggregation and the slope of platelet aggregation at the two final concentrations of ADP used. These results are compatible with the possibility that the vessel wall releases smooth muscle-relaxing prostaglandins when injured and that the inhibition of prostaglandin formation by hydrocortisone enhances hemostasis by allowing vasoconstriction to be maintained. Further investigations could be useful utilizing different concentrations of hydrocortisone in order to apply the knowledge of the effect of glucocorticoids on platelet aggregation. © 2010 Springer-Verlag London Limited.
引用
收藏
页码：327 / 331
页数：4
相关论文
共 38 条
  • [1] Akopov S.E., Gabrielian E.S., Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced y different aggregating agents alone and in combination, Eur J Clin Pharmacol, 42, pp. 257-259, (1992)
  • [2] Annane D., Sebille V., Charpentier C., Bollaert P., Francois B., Korach J., Capellier G., Cohen Y., Azoulay E., Troche G., Chaumet-Riffaut P., Bellissant E., Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock, Jama, 288, pp. 862-871, (2002)
  • [3] Angelucci L., The glucocorticoid hormone: from pedestal to dust and back, Eur J Pharmacol, 405, pp. 139-147, (2000)
  • [4] Begent N.A., Born G.C.R., Comparison of the effects of drugs on the aggregation of hamster platelets in vivo and in vitro, Br J Pharmac, 43, pp. 580-592, (1971)
  • [5] Blajchman M.A., Senyi A.F., Hirsh J., Surya Y., Buchanan M., Mustard J.F., Shortening of the bleeding time in rabbits by hydrocortisone caused by inhibition of prostacyclin generation by the vessel wall, J Clin Invest, 63, pp. 1026-1035, (1979)
  • [6] Brooks A.C., Menzies-Gow J., Wheeler-Jones P.D., Bailey S.R., Elliott J., Cunningham F.M., Regulation of platelet activating factor-induced equine platelet activation by intracellular kinases, J Vet Pharmacol Therap, 32, pp. 189-196, (2009)
  • [7] Cambridge H., Lees P., Hooke R.E., Russell C.S., Antithrombotic actions of aspirin in the horse, Equine Vet J, 23, pp. 123-127, (1991)
  • [8] Choi J.W., Influence of caffeine on the responsiveness of human platelet to agonists, Thrombosis Res, 110, pp. 209-212, (2003)
  • [9] Daniel J.L., Dangelmaier C., Jin J., Ashby B., Smith J.B., Kunapuli S.P., Molecular basis for ADP-induced platelet aggregation, J Biol Chem, 273, pp. 2024-2029, (1998)
  • [10] Fatti L.M., Bottasso B., Invitti C., Coppola R., Cavagnini F., Mannucci P.M., Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome, J Endocrinol Invest, 23, pp. 145-150, (2000)
1234